
German pharmaceutical giant Merck and a US partner reported promising results Saturday in trials of a drug administered orally to fight Covid-19, saying it helps reduce patients' viral load.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2Pxu9tU
via
IFTTT
0 comments:
Post a Comment